Holen Sie sich die Stockscreener-App
93.33
0.56%
0.52
Vorhandelsmarkt:
93.52
0.19
+0.20%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$92.81
Offen:
$92.54
24-Stunden-Volumen:
7.15M
Relative Volume:
0.96
Marktkapitalisierung:
$119.71B
Einnahmen:
$34.20B
Nettoeinkommen (Verlust:
$4.69B
KGV:
25.71
EPS:
3.63
Netto-Cashflow:
$5.30B
1W Leistung:
+1.25%
1M Leistung:
+4.47%
6M Leistung:
+1.42%
1J Leistung:
+5.36%
1-Tages-Spanne:
$92.41
$93.83
1-Wochen-Bereich:
$91.33
$93.83
52-Wochen-Spanne:
$79.29
$96.25
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Vergleichen Sie MDT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
|
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
Infusion Pump Market to Reach USD 23.13 Billion by 2032, Driven by Rising Chronic Disease Burden & Tech Innovation | SNS Insider - GlobeNewswire Inc.
How to escape a deep drawdown in Medtronic plc2025 Geopolitical Influence & Verified Momentum Stock Watchlist - Newser
Identifying reversal signals in Medtronic plcJuly 2025 Final Week & Risk Managed Investment Signals - Newser
How hedge fund analytics apply to Medtronic plc stockPortfolio Return Report & Real-Time Market Sentiment Alerts - Newser
Medtronic Stock: Is MDT Outperforming the Healthcare Sector? - MSN
Medtronic Stock: Is MDT Outperforming The Healthcare Sector? - Barchart.com
Medtronic Receives FDA Clearance for MiniMed-Abbott Sensor Integration and Approval for Type 2 Diabetes Use - Medical Device and Diagnostic industry
Medtronic advances Abbott partnership with FDA nod - MedTech Dive
FDA Approves Medtronic's (MDT) MiniMed 780G Pump for Broader Use - GuruFocus
Medtronic wins FDA nod to integrate Abbott’s Instinct sensor with MiniMed 780G - Seeking Alpha
Medtronic data highlights safety, performance of OmniaSecure defibrillation lead - MassDevice
Medtronic gets FDA OK to integrate Minimed with Abbott’s Instinct - BioWorld MedTech
What candlestick patterns are forming on Medtronic plc2025 Market Sentiment & Daily Stock Trend Reports - Newser
TD Cowen Affirms Buy Rating on Medtronic, Inc. (MDT) on RDN Therapy Prospects - Yahoo Finance
Reversal indicators forming on Medtronic plc stockMarket Movers & AI Driven Stock Reports - Newser
Medtronic gets FDA nods for MiniMed 780G with Abbott Instinct sensor, expansion to type 2 - MassDevice
Medtronic Says FDA Clears Diabetes Treatment System for Integration With Abbott's Instinct Sensor - MarketScreener
Medtronic : Compelling data at ESC Congress 2025 reinforce safety and performance of the Medtronic OmniaSecure™ defibrillation lead, including in the left bundle branch area - MarketScreener
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes - Medtronic
FDA Clears MiniMed 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes - MarketScreener
Medtronic’s SWOT analysis: stock outlook amid innovation and challenges - Investing.com
Analyzing Medtronic plc with risk reward ratio chartsMarket Sentiment Report & Daily Stock Trend Reports - Newser
Medtronic's (NYSE:MDT) Earnings May Just Be The Starting Point - 富途牛牛
Published on: 2025-09-02 04:59:17 - Newser
Is Medtronic plc benefiting from innovation trendsJuly 2025 Intraday Action & Technical Buy Zone Confirmation - خودرو بانک
Is Medtronic plc’s ROIC above industry averageJuly 2025 Update & Reliable Intraday Trade Plans - خودرو بانک
Risk Analysis: What drives Medtronic plc’s stock pricePortfolio Gains Report & Smart Investment Allocation Insights - خودرو بانک
EPS Watch: Is Medtronic plc stock suitable for long term investingJuly 2025 Setups & Verified Trade Idea Suggestions - خودرو بانک
Targets Report: What is Medtronic plc’s TAM (Total Addressable Market)July 2025 Macro Moves & Entry Point Confirmation Alerts - خودرو بانک
Real time pattern detection on Medtronic plc stockEarnings Recap Summary & Growth Focused Investment Plans - Newser
Can Medtronic plc sustain earnings growthWeekly Investment Report & Technical Entry and Exit Tips - خودرو بانک
Using portfolio simulators with Medtronic plc included2025 AllTime Highs & Advanced Swing Trade Entry Alerts - Newser
How to monitor Medtronic plc with trend dashboardsPortfolio Gains Report & Daily Growth Stock Investment Tips - Newser
Medtronic plc stock momentum explainedJuly 2025 Movers & Breakout Confirmation Trade Signals - Newser
J&J Challenges Medtronic At The Top Of Medtech Rankings - Generics Bulletin
Heatmap Data Shows High Activity in Medtronic plc Sector getLinesFromResByArray error: size == 0 - thegnnews.com
Analyzing recovery setups for Medtronic plc investorsCPI Data & Weekly Breakout Stock Alerts - Newser
Can Medtronic plc recover in the next quarter2025 Market Sentiment & Safe Entry Zone Tips - Newser
Pattern Scan Adds Medtronic plc to Watchlist getLinesFromResByArray error: size == 0 - thegnnews.com
Smart tools for monitoring Medtronic plc’s price actionTrade Entry Summary & Fast Gaining Stock Strategy Reports - Newser
Building trade automation scripts for Medtronic plcJuly 2025 Trends & Stock Portfolio Risk Management - Newser
What MACD and RSI say about Medtronic plcEarnings Beat & Low Drawdown Investment Strategies - Newser
Is Medtronic plc stock bottoming out2025 Technical Patterns & Growth Focused Stock Pick Reports - Newser
Will Medtronic plc benefit from macro trendsJuly 2025 Action & Daily Growth Stock Investment Tips - Newser
Applying chart zones and confluence areas to Medtronic plcWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser
Ranking Medtronic plc among high performing stocks via toolsEarnings Summary Report & Expert Curated Trade Setup Alerts - Newser
Can volume confirm reversal in Medtronic plcJuly 2025 Selloffs & Risk Managed Investment Strategies - Newser
Medtronic plc stock outlook for YEARIPO Watch & Free Fast Gain Swing Trade Alerts - Newser
Medtronic outlines acceleration to 5% organic revenue growth and raises EPS guidance to $5.60-$5.66, driven by CAS and innovation investments - MSN
Medtronic executives to speak at upcoming investor conferences - The Malaysian Reserve
Medtronic plc Enters Reversal Setup in Weekly Charts getLinesFromResByArray error: size == 0 - thegnnews.com
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):